AxoGen, Inc. (AXGN) PT Raised to $9.50 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AXGN Hot Sheet
Price: $51.35 +3.74%
Rating Summary:
17 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Rating Summary:
17 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Join SI Premium – FREE
Jefferies analyst Michael Sarcone raised the price target on AxoGen, Inc. (NASDAQ: AXGN) to $9.50 (from $9.00) while maintaining a Buy rating.
You May Also Be Interested In
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Precigen Inc. (PGEN) PT Raised to $12 at Citizens on 'Stellar Quarter for PAPZIMEOS'
- LeMaitre Vascular (LMAT) PT Lowered to $110 at Citizens on Slight EPS, EBITDA Misses
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
